|
|||||
|
|
| 急性髓系白血病的诊断及治疗:现状与挑战 | |
| 引用本文： | 常英军,陈苏宁. 急性髓系白血病的诊断及治疗:现状与挑战[J]. 白血病．淋巴瘤, 2017, 26(11). DOI: 10.3760/cma.j.issn.1009-9921.2017.11.001 |
| 作者姓名： | 常英军 陈苏宁 |
| 作者单位： | 100044,北京大学人民医院 北京大学血液病研究所 造血干细胞移植治疗血液病北京市重点实验室;215006,苏州大学附属第一医院血液科江苏省血液病研究所 |
| 摘 要： | 近年来,对急性髓系白血病(AML)生物学特性认识的深入促进了分类和危险分层的更新,微小残留病检测丰富了AML的预后体系,单倍型相合移植等手段为AML患者提供了更多选择. |
| 关 键 词： | 白血病 髓样 急性 微小残留病 危险分层 单倍型相合移植 |
Diagnosis and treatment of acute myeloid leukemia: current status and future challenges |
|
| Chang Yingjun,Chen Suning. Diagnosis and treatment of acute myeloid leukemia: current status and future challenges[J]. Journal of Leukemia & Lymphoma, 2017, 26(11). DOI: 10.3760/cma.j.issn.1009-9921.2017.11.001 | |
| Authors: | Chang Yingjun Chen Suning |
| Abstract: | In recent years, the advances in the comprehension of the biological characteristics of acute myeloid leukemia (AML) promote the diagnosis and risk stratification. The clinical routine detection of minimal residual disease makes prognosis system more plentiful. More strategies for AML including haploidentical transplantation and target therapy were established. |
| Keywords: | Leukemia myeloid acute Minimal residual disease Risk stratification Haploidentical transplantation |
| 本文献已被 万方数据 等数据库收录！ | |